Table of Content

Chapter 1.    Executive Summary: Global Chronic Disease Management Market
Chapter 2.    Research Methodology & Research Framework

2.1.    Research Objective
2.2.    Product Overview
2.3.    Market Segmentation
2.4.    Qualitative Research
2.4.1.    Primary & Secondary Sources
2.5.    Quantitative Research
2.5.1.    Primary & Secondary Sources
2.6.    Breakdown of Primary Research Respondents, By Region
2.7.    Assumption for Study
2.8.    Market Size Estimation
2.9.    Data Triangulation

Chapter 3.    Global Chronic Disease Management Market Overview

3.1.    Industry Value Chain Analysis
3.1.1.    Material Provider
3.1.2.    Manufacturer
3.1.3.    Distributor
3.1.4.    End Users
3.2.    Industry Outlook
3.2.1.    Overview of Chronic Disease Management Market
3.2.2.    EXIM Data
3.3.    PESTLE Analysis
3.4.    Porter's Five Forces Analysis
3.4.1.    Bargaining Power of Suppliers
3.4.2.    Bargaining Power of Buyers
3.4.3.    Threat of Substitutes
3.4.4.    Threat of New Entrants
3.4.5.    Degree of Competition
3.5.    Market Dynamics and Trends
3.5.1.    Growth Drivers
3.5.1.1.    Increasing Prevalence of Chronic Diseases along with the Growing Geriatric Population
3.5.2.    Restraints
3.5.2.1.    High Cost of Services and Security Concerns
3.5.3.    Opportunity
3.5.3.1    Novel Technological Advancements and Rising Healthcare Expenditure
3.5.4.    Key Trend
3.6.    Market Growth and Outlook
3.6.1.    Market Revenue Estimates and Forecast (US$ Mn), 2025 – 2035
3.6.2.    Price Trend Analysis

Chapter 4.    Competition Dashboard

4.1.    Market Concentration Rate
4.2.    Company Market Share Analysis (Value %), 2025
4.3.    Competitor Mapping & Benchmarking

Chapter 5.    Global Chronic Disease Management Market Analysis

5.1.    Key Insights
5.2.    Market Size and Forecast, 2026-2035 (US$ Mn)
5.2.1.    By Disease Type
5.2.1.1.    Cardiovascular diseases
5.2.1.2.    Diabetes
5.2.1.3.    Cancer
5.2.1.4.    Asthma
5.2.1.5.    Chronic obstructive pulmonary disorders
5.2.1.6.    Others
5.2.2.    By Type
5.2.2.1.    Solutions
5.2.2.2.    Services
5.2.3.    By End User
5.2.3.1.    Healthcare Providers Services
5.2.3.2.    Healthcare Payers
5.2.3.3.    Others
5.2.4.    By Region
5.2.4.1.    North America
5.2.4.1.1.    The U.S.
5.2.4.1.2.    Canada
5.2.4.1.3.    Mexico
5.2.4.2.    Europe   
5.2.4.2.1.    Western Europe
5.2.4.2.1.1.    The UK
5.2.4.2.1.2.    Germany
5.2.4.2.1.3.    France
5.2.4.2.1.4.    Italy
5.2.4.2.1.5.    Spain
5.2.4.2.1.6.    Rest of Western Europe
5.2.4.2.2.    Eastern Europe
5.2.4.2.2.1.    Poland
5.2.4.2.2.2.    Russia
5.2.4.2.2.3.    Rest of Eastern Europe
5.2.4.3.    Asia Pacific
5.2.4.3.1.    China
5.2.4.3.2.    India
5.2.4.3.3.    Japan
5.2.4.3.4.    South Korea
5.2.4.3.5.    Australia & New Zealand
5.2.4.3.6.    ASEAN
5.2.4.3.7.    Rest of Asia Pacific
5.2.4.4.    Middle East & Africa
5.2.4.4.1.    UAE
5.2.4.4.2.    Saudi Arabia
5.2.4.4.3.    South Africa
5.2.4.4.4.    Rest of MEA
5.2.4.5.    South America
5.2.4.5.1.    Argentina
5.2.4.5.2.    Brazil
5.2.4.5.3.    Rest of South America

Chapter 6.    North America Chronic Disease Management Market Analysis

6.1.    Market Dynamics and Trends
6.1.1.    Growth Drivers
6.1.2.    Restraints
6.1.3.    Opportunity
6.1.4.    Key Trends
6.2.    Market Size and Forecast, 2026-2035 (US$ Mn)
6.2.1.    By Disease Type
6.2.2.    By Type
6.2.3.    By End User 
6.2.4.    By Region

Chapter 7.    Europe Chronic Disease Management Market Analysis

7.1.    Market Dynamics and Trends
7.1.1.    Growth Drivers
7.1.2.    Restraints
7.1.3.    Opportunity
7.1.4.    Key Trends
7.2.    Market Size and Forecast, 2026-2035 (US$ Mn)
7.2.1.    By Disease Type
7.2.2.    By Type
7.2.3.    By End User 
7.2.4.    By Region

Chapter 8.    Asia Pacific Chronic Disease Management Market Analysis

8.1.    Market Dynamics and Trends
8.1.1.    Growth Drivers
8.1.2.    Restraints
8.1.3.    Opportunity
8.1.4.    Key Trends
8.2.    Market Size and Forecast, 2026-2035 (US$ Mn)
8.2.1.    By Disease Type
8.2.2.    By Type
8.2.3.    By End User 
8.2.4.    By Region

Chapter 9.    Middle East & Africa Chronic Disease Management Market Analysis

9.1.    Market Dynamics and Trends
9.1.1.    Growth Drivers
9.1.2.    Restraints
9.1.3.    Opportunity
9.1.4.    Key Trends
9.2.    Market Size and Forecast, 2026-2035 (US$ Mn)
9.2.1.    By Disease Type
9.2.2.    By Type
9.2.3.    By End User 
9.2.4.    By Region

Chapter 10.    South America Chronic Disease Management Market Analysis

10.1.    Market Dynamics and Trends
10.1.1.    Growth Drivers
10.1.2.    Restraints
10.1.3.    Opportunity
10.1.4.    Key Trends
10.2.    Market Size and Forecast, 2026-2035 (US$ Mn)
10.2.1.    By Disease Type
10.2.2.    By Type
10.2.3.    By End User 
10.2.4.    By Region

Chapter 11.    Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

11.1.    Hinduja Global Solutions Ltd
11.2.    Koninklijke Philips N.V
11.3.    Cognizant TriZetto Software Group Inc
11.4.    Vivify Health, Inc
11.5.    cliexa, Inc
11.6.    Pegasystems Inc
11.7.    Cedar Gate Technologies
11.8.    Altruista Health
11.9.    Casenet, LLC
11.10.    Infosys Ltd
11.11.    Health Catalyst
11.12.    ExlServings Holdings, Inc
11.13.    Medecision
11.14.    ZeOmega
11.15.    Epic Systems Corporation
11.16. Allscripts Healthcare, LLC
11.17. NXGN Management, LLC
11.18. Others

Chapter 12.    Annexure

12.1.    List of Secondary Sources
12.2.    Macro Economic Outlook/Indicators